The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 79-84 , January 2010

Advances in adult asthma diagnosis and treatment in 2009

  • Andrea J. Apter, MD, MSc

      Affiliations

    • Corresponding Author InformationReprint requests: Andrea J. Apter, MD, MSc, 829 Gates Bldg, Hospital of the University of Pennsylvania, 3600 Spruce St, Philadelphia, PA 19104.

Received 17 November 2009 ,Accepted 19 November 2009.

References 

  1. Apter AJ. Clinical advances in adult asthma. J Allergy Clin Immunol. 2003;111(suppl):S780–S784
  2. Apter AJ. Advances in adult asthma 2006: its risk factors, course, and management. J Allergy Clin Immunol. 2007;119:563–566
  3. Apter AJ. Advances in the care of adults with asthma and allergy in 2007. J Allergy Clin Immunol. 2008;121:839–844
  4. Apter AJ. Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008. J Allergy Clin Immunol. 2009;123:35–40
  5. Apter AJ, Szefler SJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol. 2004;113:407–414
  6. Apter AJ, Szefler SJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol. 2006;117:512–518
  7. Szefler SJ, Apter A. Advances in pediatric and adult asthma. J Allergy Clin Immunol. 2005;115:470–477
  8. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99
  9. Fulbrigge A, Golden WE. National Committee for Quality Assurance, the Physician Consortium for Performance Improvement, Quality of Care Measurement, Asthma. Chicago: American Medical Association and National Committee for Quality Assurance; 2009;p. 1-53
  10. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol. 2007;120:238–246
  11. He JQ, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, et al. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol. 2009;124:222–229
  12. Barton SJ, Koppelman GH, Vonk JM, Browning CA, Nolte IM, Stewart CE, et al. PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline. J Allergy Clin Immunol. 2009;123:1391–1400e17
  13. Haller G, Torgerson D, Ober C, Thompson EE. Sequencing the IL4 locus in African Americans implicates rare noncoding variants in asthma susceptibility. J Allergy Clin Immunol. 2009;124:1204–1209
  14. Basu K, Palmer CN, Tavendale R, Lipworth BJ, Mukhopadhyay S. Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. J Allergy Clin Immunol. 2009;124:1188–1194
  15. Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124:719–723
  16. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65
  17. Yong PL, Werner RM. Process quality measures and asthma exacerbations in the Medicaid population. J Allergy Clin Immunol. 2009;124:961–966
  18. Lund MB, Kongerud J, Nystad W, Boe J, Harris JR. Genetic and environmental effects on exhaled nitric oxide and airway responsiveness in a population-based sample of twins. Eur Respir J. 2007;29:292–298
  19. Smith AD, Cowan JO, Taylor DR. Exhaled nitric oxide levels in asthma: Personal best versus reference values. J Allergy Clin Immunol. 2009;124:714–718
  20. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008;372:1065–1072
  21. Gruchalla RS, Sampson HA, Matsui E, David G, Gergen PJ, Calatroni A, et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol. 2009;124:213–221e1
  22. Gergen PJ, Arbes SJ, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2009;124:447–453
  23. Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol. 2009;124:45–51e1-4
  24. Wu AC, Tantisira K, Li L, Schuemann B, Weiss S. Repeatability of response to asthma medications. J Allergy Clin Immunol. 2009;123:385–390
  25. Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Diagnostic properties of inhaled mannitol in the diagnosis of asthma: a population study. J Allergy Clin Immunol. 2009;124:928–932
  26. Rothman KJ. Epidemiology, an introduction. Oxford: Oxford University Press; 2002;p. 199-201
  27. Patel MM, Miller RL. Air pollution and childhood asthma: recent advances and future directions. Curr Opin Pediatr. 2009;21:235–242
  28. Sucharew H, Ryan PH, Bernstein D, Succop P, Khurana Hershey GK, Lockey J, et al. Exposure to traffic exhaust and night cough during early childhood: the CCAAPS birth cohort. Pediatr Allergy Immunol. In press.
  29. Balmes JR, Earnest G, Katz PP, Yelin EH, Eisner MD, Chen H, et al. Exposure to traffic: lung function and health status in adults with asthma. J Allergy Clin Immunol. 2009;123:626–631
  30. Alexis NE, Zhou H, Lay JC, Harris B, Hernandez ML, Lu TS, et al. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy Clin Immunol. 2009;124:1222–1228
  31. DeMore JP, Weisshaar EH, Vrtis RF, Swenson CA, Evans MD, Morin A, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol. 2009;124:245–252e1-3
  32. Sternthal MJ, Enlow MB, Cohen S, Canner MJ, Staudenmayer J, Tsang K, et al. Maternal interpersonal trauma and cord blood IgE levels in an inner-city cohort: a life-course perspective. J Allergy Clin Immunol. 2009;124:954–960
  33. Holbrook JT, Harik-Khan R. Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials. J Allergy Clin Immunol. 2008;122:828–829
  34. Philip G, Hustad C. Analysis of behavior related adverse experiences in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124:699–706
  35. Philip G, Hustad C, Noonan G, Malice M, Ezekowitz A, Reiss TF, et al. Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124:691–696
  36. Kelsay K. Assessing risk: data from montelukast clinical trials. J Allergy Clin Immunol. 2009;124:697–698
  37. Hope AP, Woessner KA, Simon RA, Stevenson DD. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2009;123:406–410
  38. Wise RA, Bartlett SJ, Brown ED, Castro M, Cohen R, Holbrook JT, et al. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol. 2009;124:436–444e1-8
  39. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999;14:32–38
  40. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest. 1998;114:998–1007
  41. Thomas M, von Ziegenweidt J, Lee AJ, Price D. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. J Allergy Clin Immunol. 2009;123:116–121e10
  42. Pavord ID, Jeffery PK, Qiu Y, Zhu J, Parker D, Carlsheimer A, et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol. 2009;123:1083–1089e1-7
  43. Haahtela T, Tamminen K, Kava T, Malmberg P, Rytila P, Nikander K, et al. Thirteen-year follow up results of early intervention with an inhaled corticosteroid in patients with asthma. J Allergy Clin Immunol. 2009;124:1180–1185
  44. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388–392
  45. Matsui EC, Matsui W. Higher serum folate levels are associated with a lower risk of atopy and wheeze. J Allergy Clin Immunol. 2009;123:1253–1259e2
  46. Tsai CL, Sullivan AF, Gordon JA, Kaushal R, Magid DJ, Blumenthal D, et al. Quality of care for acute asthma in 63 US emergency departments. J Allergy Clin Immunol. 2009;123:354–361
  47. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda: Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1997;Publication no. 97-4051
  48. Expert panel report: guidelines for the diagnosis and management of asthma. Update on selected topics—2002. J Allergy Clin Immunol. 2002;110(suppl):S141–S218
  49. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute; 2007;p. 1-416, NIH Publication no. 08-5846
  50. Macsali F, Real FG, Omenaas ER, Bjorge L, Janson C, Franklin K, et al. Oral contraception, body mass index, and asthma: a cross-sectional Nordic-Baltic population survey. J Allergy Clin Immunol. 2009;123:391–397
  51. Temprano J, Mannino DM. The effect of sex on asthma control from the National Asthma Survey. J Allergy Clin Immunol. 2009;123:854–860
  52. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, et al. National surveillance for asthma—United States, 1980-2004. MMWR Surveill Summ. 2007;56:1–54
  53. Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009;123:124–130e1
  54. Cookson H, Granell R, Joinson C, Ben-Shlomo Y, Henderson AJ. Mothers' anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol. 2009;123:847–853e11
  55. Blais L, Beauchesne M-F, Lemiere C, Elftouh N. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol. 2009;124:1229–1234
  56. Clerisme-Beaty EM, Karam S, Rand C, Patino CM, Bilderback A, Riekert KA, et al. Does higher body mass index contribute to worse asthma control in an urban population?. J Allergy Clin Immunol. 2009;124:207–212
  57. Marcon A, Corsico A, Cazzoletti L, Bugiani M, Accordini S, Almar E, et al. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol. 2009;123:1069–1074e1-4
  58. Coogan PF, Palmer JR, O'Connor GT, Rosenberg L. Body mass index and asthma incidence in the Black Women's Health Study. J Allergy Clin Immunol. 2009;123:89–95
  59. Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol. 2009;123:1328–1334e1
  60. Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemiere C, et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124:371–376
  61. Janson SL, McGrath KW, Covington JK, Cheng SC, Boushey HA. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol. 2009;123:840–846
  62. Naimi DR, Freedman TG, Ginsburg KR, Bogen D, Rand CS, Apter AJ. Adolescents and asthma: why bother with our meds?. J Allergy Clin Immunol. 2009;123:1335–1341
  63. Bryant-Stephens T. Asthma disparities in urban environments. J Allergy Clin Immunol. 2009;123:1199–1208
  64. Canino G, McQuaid EL, Rand CS. Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol. 2009;123:1209–1219
  65. Valet RS, Perry TT, Hartert TV. Rural health disparities in asthma care and outcomes. J Allergy Clin Immunol. 2009;123:1220–1225
  66. Apter AJ, Casillas AM. Eliminating health disparities: what have we done and what do we do next?. J Allergy Clin Immunol. 2009;123:1237–1239
  67. National Assessment of Adult Literacy. National Center for Education Statistics; Institute of Education Sciences; US Department of Education. http://nces.ed.gov/naal/. Accessed November 11, 2009.
  68. Apter AJ, Cheng J, Small D, Bennett IM, Albert C, Fein DG, et al. Asthma numeracy skill and health literacy. J Asthma. 2006;43:705–710
  69. Apter AJ, Paasche-Orlow MK, Remillard JT, Bennett IM, Ben-Joseph EP, Batista RM, et al. Numeracy and communication with patients: they are counting on us. J Gen Intern Med. 2008;23:2117–2124
  70. Adams RJ, Appleton SL, Hill CL, Ruffin RE, Wilson DH. Inadequate health literacy is associated with increased asthma morbidity in a population sample. J Allergy Clin Immunol. 2009;124:601–603
  71. Weiss BD, Mays MZ, Martz W, Castro KM, DeWalt DA, Pignone MP, et al. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med. 2005;3:514–522
  72. Paasche-Orlow MK, Riekert KA, Bilderback A, Chanmugam A, Hill P, Rand CS, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005;172:980–986
  73. Esteban CA, Klein RB, McQuaid EL, Fritz GK, Seifer R, Kopel SJ, et al. Conundrums in childhood asthma severity, control, and health care use: Puerto Rico versus Rhode Island. J Allergy Clin Immunol. 2009;124:238–244e1-5
  74. Martin MA, Catrambone CD, Kee RA, Evans AT, Sharp LK, Lyttle C, et al. Improving asthma self-efficacy: developing and testing a pilot community-based asthma intervention for African American adults. J Allergy Clin Immunol. 2009;123:153–159e3
  75. Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. The protective effect of community factors on childhood asthma. J Allergy Clin Immunol. 2009;123:1297–1304e2

 Disclosure of potential conflict of interest: A. J. Apter receives research support from the National Heart, Lung, and Blood Institute. A. J. Apter is supported by grants HL070392, HL088469, and RC1 HL099612.

PII: S0091-6749(09)01749-7

doi: 10.1016/j.jaci.2009.11.028

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 79-84 , January 2010

Article Tools